In Just 3 Hours, The US Created A Coronavirus Vaccine, Giving Us Hope To End The COVID-19 Nightmare
Dhir Acharya - Feb 17, 2020
As soon as Chinese scientists released the coronavirus’ genetic sequence on Jan 9, the researchers began their work and developed a vaccine for the virus.
- These Indian Cities Are Under Lockdown Again In 2021
- Foreigners Required To Take COVID-19 Anal Swab Test When Visiting China
- Countries That Have Received COVID-19 Vaccines From India
As the coronavirus outbreak is infecting more people, taking away more lives in China and around the world, scientists in a laboratory in the US are working day and night to come up with a vaccine for the virus and bring it to the market as soon as possible. The good news is Inovio Pharmaceuticals is coming closer to releasing a vaccine against the coronavirus. Previously, Inovio Pharmaceuticals also created vaccines for Zika, MERS, and Ebola.
Inovio’s director of R&D, Dr. Trevor Smith, said that this is something they were trained to do, with the help of all the necessary infrastructure and the expertise. On January 9, as soon as scientists in China released the coronavirus’ genetic sequence, researchers at Inovio began their work and it took them only 3 hours to develop a vaccine for the coronavirus, which is now officially called COVID-19.
According to Dr. Smith, the research team used their own algorithm, they put the DNA sequence of the virus into the algorithm and came up with a vaccine.
Currently, there are tens of thousands of people in quarantine in China and the country continues to suffer from the spread of the coronavirus, which is why researchers at Inovio feel the urgency to get the vaccine ready as quickly as they could.
So far, the researchers have tested the vaccine on guinea pigs and mice, and will next test it on a group of human patients. The vaccine is hoped to work like some kind of biological software, meaning it’s expected to instruct the human body to generate the proper attack using antibodies and T-cells to fight the coronavirus.
If everything goes well, they can start clinical trials on human patients as early as this summer, but they need to be approved by the FDA for that.
Comments
Sort by Newest | Popular